Sign up to save your podcasts
Or
Share Trabectedin for recurrent grade 2 or 3 meningiomas
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Trabectedin for recurrent grade 2 or 3 meningiomas
Dr. Iyad Alnahhas interviews Dr. Matthias Preusser about the recent manuscript entitled: "Trabectedin for recurrent WHO grade 2 or 3 meningioma: a randomized phase 2 study of the EORTC Brain Tumor Group (EORTC-1320-BTG)", published online in Neuro-Oncology in October 2021.
View all episodes
By Neuro-Oncology
4.8
1212 ratings
Dr. Iyad Alnahhas interviews Dr. Matthias Preusser about the recent manuscript entitled: "Trabectedin for recurrent WHO grade 2 or 3 meningioma: a randomized phase 2 study of the EORTC Brain Tumor Group (EORTC-1320-BTG)", published online in Neuro-Oncology in October 2021.
More shows like Neuro-Oncology: The Podcast
View all
Wait Wait... Don't Tell Me!
38,520 Listeners
This American Life
90,828 Listeners
Neurology® Podcast
288 Listeners
Science Vs
11,792 Listeners
Radio Atlantic
2,273 Listeners
Armchair Expert with Dax Shepard
69,215 Listeners
Call Her Daddy
165,587 Listeners
Conan O’Brien Needs A Friend
59,208 Listeners
The Cribsiders
315 Listeners
IMO with Michelle Obama and Craig Robinson
12,857 Listeners
Huberman Lab
28,512 Listeners
The Ezra Klein Show
15,363 Listeners
If Books Could Kill
8,890 Listeners
Not Gonna Lie with Kylie Kelce
9,943 Listeners
Good Hang with Amy Poehler
7,679 Listeners